Negative Pressure Wound Therapy: Reimbursement situation of this medical device 15 years after entering the European Market
AbstractGetting adequate reimbursement for new and innovative medical devices is crucial for a successful uptake of the product in the market. However in the last years payers and authorities pushed for more detailed evaluations of the actual benefits of new medical devices before granting reimbursement. These assessment are often based on established Health-Technology-Assessments methods developed for pharmaceuticals. But as medical devices and pharmaceuticals differ in many ways these processes often do not work as smoothly as hoped and necessary. The history and current reimbursement situation of Negative-Pressure-Wound-Therapy (NPWT) is an example for these issues. Despite being on the market for over fifteen years in Europe and backed up by clinical and economic studies only Germany, Switzerland, Netherland, Sweden and Slovakia do have a dedicated reimbursement for NPWT in the inpatient sector. In the outpatient sector the reimbursement situation is even bleaker as only Switzerland and Austria have a fully functioning reimbursement in place. In Germany reimbursement decision are taken on a case-by-case base while in England only the dressings are reimbursed but not the equipment itself. In France only usage in the home hospitalisation sector is reimbursed. This situation cannot be satisfying for patients, physicians, payers and manufacturers. In order to improve the uptake of new medical devices manufacturer need to focus earlier on creating solid clinical evidence while payers also have to adapt their health-technology-assessments and take the differences of medical devices compared to pharmaceuticals into account.
Sorenson, C.D., M.; Burns L. R.; , Evolving Reimbursement and Pricing policies for devices in Europe and the United States should encourage greater value. Health Affairs, 2013. 4: p. 788-796.
Drummond, M.G., A.; Tarricone, R., Economic Evaluation for Devices and Drugs-Same or Different. Value in Health, 2009. 12(4): p. 402-406.
The Theory and Practice of Vacuum Therapy, ed. C. Willy. 2006: Lindquist book-publishing, Ulm.
Nord, D., Cost-effectiveness in wound care. Zentralbl Chir, 2006. 131: p. S 185-188.
Busse, R.G., A.; Quentin W.; Wiley M.; , ed. Diagnosis-Related Groups in Europe. European Observatory on Health Systems and Policies Series, ed. M.M. J. Figueras, E. Mossilos, R. B. Saltmann, R. Busse. 2011, McGraw-Hill Education: Open University Press. 447.
Office fédéral de la statistique (OFS), “Schweizerische Operationsklassifikation (CHOP) Systematisches Verzeichnis – Version 2015,” 2015. [Online]. Available: http://www.bfs.admin.ch/bfs/portal/ de/index/news/publikationen.html?publicationID=5660
Werken met dbc’s ziekenhuiszorg, “Praktische uitleg en documentatie bij de dbc-systematiek,” 2015
NordDRG ICD+ and NCSP+ platforms, “Basic classification,” no. 2, 2014. [Online]. Available: http://www.nordcase.org/eng/materials/ basic-classification/
Gemeinsamer Bundesausschuss Abteilung Methodenbewertung und veranlasste Leistungen , “Vakuumversiegelungstherapie,” Zusammenfassende Dokumentation des Unterausschusses „Ärztliche Behandlung“ des Gemeinsamen Bundesausschusses, 2008. [Online]. Available: https: //www.g-ba.de/downloads/40-268-538/2008-02-15-Abschluss-VAC.pdf
Gemeinsamer Bundesausschuss, “Tragende gründe zum beschluss des gemeinsamen bundesausschusses über eine Änderung der richtlinie methoden vertragsärztliche versorgung: Verlängerung der aussetzung des bewertungsverfahrens zur vakuumversiegelungstherapie von wunden,” 2014. [Online]. Available: https://www.g-ba.de/downloads/40-268-3009/2014-11-20_ MVV-RL_Verlaengerung-Aussetzung-VAC_TrG.pdf
Terrade, O.T., T.; Cottencin A.; , Hospital care at home in France: an alternative to conventional hospitalization with the same obligations towards quality and administration. Journal of the National Institute of Public Health, 2012. 61(2): p. 148-154.
Dowsett, C., et al., The economic benefits of negative pressure wound therapy in community-based wound care in the NHS. International wound journal, 2012. 9(5): p. 544-52.
Copyright (c) 2016 Joerg Linder
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
We require authors to sign a Publication Agreement prior to publication of the manuscript in NPWTJ. The link to this form may be found below.
PUBLICATION AGREEMENT FORM